[144] WESTLAKE CHEMICAL PARTNERS LP SEC Filing

Rhea-AI Filing Summary

Westlake Chemical Partners LP (WLKP) filing a Form 144 notifies the proposed sale of 12,000 common shares through UBS Financial Services (Weehawken, NJ) with an approximate aggregate market value of $263,400. The shares represent part of the issuer's outstanding common of 35,238,556 and the sale is scheduled for 08/15/2025 on the NYSE. The shares were originally acquired in an IPO purchase on 07/30/2014 and paid in cash. The filer declares no sales in the past three months and signs the required representation regarding material nonpublic information.

Positive

• Full transaction details provided: class, broker, share count, aggregate value, acquisition date, payment method, and planned sale date are disclosed
• Long-term ownership: shares were acquired at the IPO on 07/30/2014, indicating a long-held position

Negative

• Missing filer identity: the provided excerpt does not include the name/CIK or the relationship of the selling person to the issuer
• Insufficient contact details: submission contact fields are blank in the excerpt, limiting follow-up or verification

Insights

Securities Analyst

TL;DR Small planned sale of WLKP common by an IPO-era holder; disclosure is routine and likely immaterial to valuation.

This Form 144 states a proposed sale of 12,000 WLKP shares valued at $263,400 to be executed via UBS on 08/15/2025. The position was acquired at the IPO on 07/30/2014 and paid in cash, indicating a long-held insider or affiliate disposition. No sales in the prior three months are reported, suggesting this is an isolated planned sale rather than part of ongoing liquidation. The filing omits the identity and relationship of the selling person in the provided excerpt, which limits interpretation of potential insider signaling. Given the size relative to 35.24 million shares outstanding (~0.034%), the direct market impact is likely negligible.

Corporate Governance Expert

TL;DR Form 144 disclosure meets procedural requirements but lacks named filer details in the supplied text.

The notice documents the mechanics of a proposed Rule 144 sale: broker, share count, aggregate value, acquisition date and method, and planned sale date. The seller represents no undisclosed material information, a standard certification. However, the provided content does not include the filers name, CIK or stated relationship to the issuer; these omissions prevent assessment of whether the sale arises from an insider, affiliate, or other holder and restrict governance interpretation. As filed, the transaction appears routine and non-material from a corporate-governance perspective.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	12000	263400	35238556	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2014	IPO purchase	Issuer			12000	07/30/2014	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the size and value of the WLKP shares proposed for sale?

The notice reports 12,000 common shares with an aggregate market value of $263,400.

When is the proposed sale of WLKP shares scheduled to occur?

The sale is listed with an approximate date of 08/15/2025 to be executed on the NYSE.

How and when were the WLKP shares being sold originally acquired?

The shares were acquired in an IPO purchase on 07/30/2014 and payment was made in cash.

Who is the broker handling the WLKP sale?

The broker named in the filing is UBS Financial Services Inc., 1000 Harbor Blvd, Weehawken, NJ.

Has the seller reported other WLKP sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filing indicate any undisclosed material information about WLKP?

By signing the notice the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.